Government panel recommends emergency approval for SII’s Covovax for seven-11 year olds
The recommendation has been sent to the Drugs Controller General of India (DCGI) for final approval
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi, GSK COVID-19 vaccine found effective against Omicron
The vaccine targets the beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus
Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with…
Ahammune’s investigational new drug for vitiligo- AB1001 has mechanism of action that targets pathways involved in triggering…
Smallpox drugmakers get new orders as monkeypox spreads
More than 3,000 confirmed cases of monkeypox have been reported from 40 countries where the disease is not endemic
GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in…
This research will focus on new and disruptive vaccines and medicines to prevent and treat malaria, tuberculosis, HIV NTDs and…
DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11…
The expert panel in its last meeting in April had sought more data from SII following its application seeking the Emergency Use…
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine
The DCGI recently approved Corbevax as a precaution dose for those aged 18 and above
Data security a priority for pharma companies in India: Deloitte India–DSCI report
Ransomware attacks and IP and data theft were the top cybersecurity concerns for the sector
Clevergene signs MoU with Rajiv Gandhi Centre for Biotechnology
The MoU has been signed to establish a state-of-the-art genomics centre at Thiruvananthapuram
IIT Madras partners with Ministry of AYUSH for AYURTECH 2022
The institute aims to provide a forum for AYUSH scientists and researchers to hear from experts in academia and industry, and to…